Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk

The article analyzes the indicators characterizing endothelial function in patients of distinguished groups at the initial stage of the study (visit 1) and during the treatment (visit 2). At baseline levels of endothelin-1 in the blood of patients of all groups did not differ significantly between t...

Full description

Saved in:
Bibliographic Details
Main Author: Turlyun T.S.
Format: Article
Language:English
Published: Dnipro State Medical University 2014-03-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://medpers.dsma.dp.ua/issues/2014/N1/56-63.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850058947402137600
author Turlyun T.S.
author_facet Turlyun T.S.
author_sort Turlyun T.S.
collection DOAJ
description The article analyzes the indicators characterizing endothelial function in patients of distinguished groups at the initial stage of the study (visit 1) and during the treatment (visit 2). At baseline levels of endothelin-1 in the blood of patients of all groups did not differ significantly between the groups distinguished. After treatment, the dynamics of the indicator in all groups was positive and statistically significant (p<0,05): the level of ET-1 in the group with HD decreased by 7,7%, more pronounced changes were observed in hypertensive patients with type 2 diabetes - indicator decreased by 21,7% (p<0,05), testifying to reducing of endothelin-1 formation and its entering to the blood. When comparing control and treatment groups (0,37±0,06 fmol/ml) a twofold excess of endothelin-1 in hypertensive groups (p<0,01) and in patients with hypertension and diabetes mellitus type 2 (p<0,01) was observed. After the treatment with losartan potassium and hydrochlorothiazide, a statistically significant reduction of ET-1 in the group without hypertension comorbidity (p<0,004) and in the group of hypertensive type 2 diabetic (p<0,004) was noted. Dynamics of ET-1 decrease in the group with type 2 diabetes, but statistically unreliable (p<0,233) was noted. Under the influence of losartan potassium and hydrochlorothiazide average albuminuria level decreased in groups of patients with hypertension and hypertension with type 2 diabetes (p<0,05). In patients with type 2 diabetes who were not taking antihypertensive drugs, the rate did not change (p>0,60).
format Article
id doaj-art-04903b49798649e1aec07a6cc05be3f7
institution DOAJ
issn 2307-0404
2307-0404
language English
publishDate 2014-03-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-04903b49798649e1aec07a6cc05be3f72025-08-20T02:51:00ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042307-04042014-03-011915663Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular riskTurlyun T.S. 0SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»The article analyzes the indicators characterizing endothelial function in patients of distinguished groups at the initial stage of the study (visit 1) and during the treatment (visit 2). At baseline levels of endothelin-1 in the blood of patients of all groups did not differ significantly between the groups distinguished. After treatment, the dynamics of the indicator in all groups was positive and statistically significant (p<0,05): the level of ET-1 in the group with HD decreased by 7,7%, more pronounced changes were observed in hypertensive patients with type 2 diabetes - indicator decreased by 21,7% (p<0,05), testifying to reducing of endothelin-1 formation and its entering to the blood. When comparing control and treatment groups (0,37±0,06 fmol/ml) a twofold excess of endothelin-1 in hypertensive groups (p<0,01) and in patients with hypertension and diabetes mellitus type 2 (p<0,01) was observed. After the treatment with losartan potassium and hydrochlorothiazide, a statistically significant reduction of ET-1 in the group without hypertension comorbidity (p<0,004) and in the group of hypertensive type 2 diabetic (p<0,004) was noted. Dynamics of ET-1 decrease in the group with type 2 diabetes, but statistically unreliable (p<0,233) was noted. Under the influence of losartan potassium and hydrochlorothiazide average albuminuria level decreased in groups of patients with hypertension and hypertension with type 2 diabetes (p<0,05). In patients with type 2 diabetes who were not taking antihypertensive drugs, the rate did not change (p>0,60).http://medpers.dsma.dp.ua/issues/2014/N1/56-63.pdfarterial hypertensiondiabetes mellitus type 2endothelial dysfunctionendothelin-1losartan potassium
spellingShingle Turlyun T.S.
Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk
Medičnì Perspektivi
arterial hypertension
diabetes mellitus type 2
endothelial dysfunction
endothelin-1
losartan potassium
title Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk
title_full Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk
title_fullStr Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk
title_full_unstemmed Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk
title_short Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk
title_sort change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk
topic arterial hypertension
diabetes mellitus type 2
endothelial dysfunction
endothelin-1
losartan potassium
url http://medpers.dsma.dp.ua/issues/2014/N1/56-63.pdf
work_keys_str_mv AT turlyunts changeinendothelialfunctionstateundertheinfluenceofantihypertensivetherapyinpatientswitharterialhypertensionandhighcardiovascularrisk